PMA stock forecast, quote, news & analysis

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 20 of 23 cases where PMA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Moving Average Convergence Divergence (MACD) for PMA just turned positive on October 14, 2026. Looking at past instances where PMA's MACD turned positive, the stock continued to rise in 15 of 16 cases over the following month. The odds of a continued upward trend are 90%.

PMA moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where PMA advanced for three days, in 66 of 75 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

The Aroon Indicator entered an Uptrend today. In 21 of 31 cases where PMA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

PMA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.208) is normal, around the industry mean (15.499). P/E Ratio (8.207) is within average values for comparable stocks, (168.807). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.185) among similar stocks. P/S Ratio (1.118) is also within normal values, averaging (2.905).

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. PMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.